Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.

Student honorees selected by faculty, staff and classmates were recognized at the annual Awards Ceremony and Commencement Banquet

A cure to hepatitis C is within reach

Even moderate drinking isn’t good for you. So how much is?

RUSH University’s 51st Commencement Ceremony highlights the important role every health care worker plays in their community

Your smile reveals more than just your teeth. A RUSH expert explains the importance of smiling for good health.

Preeclampsia and HELLP syndrome led to a scary few weeks for Chade and her baby. Awareness may help save lives

Men comprise less than 10% of the nursing workforce — but the faculty and students leading the RUSH Men in Nursing organization are working to change that

Waterford Place participants turn poetic to share their feelings about cancer

The EP lab will treat patients with and abnormal heart rhythms and other heart related conditions closer to home